HBT
WST icon

Heartland Bank & Trust’s West Pharmaceutical WST Stock Holding History

Heartland Bank & Trust’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-1,037
Closed -$426K – 133
2022
Q1 		$426K Sell
1,037
-203
-16% -$79.5K 0.32% 102
2021
Q4 		$582K Buy
1,240
+23
+2% +$9.9K 0.43% 73
2021
Q3 		$517K Buy
1,217
+34
+3% +$14.3K 0.45% 70
2021
Q2 		$425K Buy
+1,183
New +$391K 0.39% 72

Other funds holding WST

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
APG Asset Management
APG Asset Management Amsterdam, Netherlands $31.6B AUM 19.33% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return

Heartland Bank & Trust's WST Position: Q2 2022 in Review

Heartland Bank & Trust sold out of West Pharmaceutical (WST) in Q2 2022, closing a stake of 1,037 shares — an estimated $426K sold.

Heartland Bank & Trust first reported a position in WST in Q2 2021 and held it in 4 quarters. The position peaked at $582K in Q4 2021. 655 funds tracked by Wall St. Rank hold WST as of Q2 2022.

  • Heartland Bank & Trust reported no remaining West Pharmaceutical position as of Q2 2022 after selling out during the quarter.
  • Heartland Bank & Trust sold 1,037 West Pharmaceutical shares in Q2 2022, an estimated $426K.
  • Heartland Bank & Trust first reported a position in West Pharmaceutical in Q2 2021 and held it in 4 quarters.
  • Heartland Bank & Trust's West Pharmaceutical position peaked at $582K in Q4 2021.
  • 655 funds tracked by Wall St. Rank held West Pharmaceutical as of Q2 2022.

Based on Heartland Bank & Trust's 13F filing for Q2 2022, filed 12 Jul 2022.